Lyka Labs - Quaterly Results

02 Aug 2023 Evaluate
Revenue reduced marginally to stand at Rs. 212.37 millions during the quarter ended June 2023. The figure stood at Rs. 218.78 millions during the year-ago period.The Net Loss for the quarter ended June 2023 is Rs. -17.20 millions as compared to Net Profit of Rs. 3.27 millions of corresponding quarter ended June 2022Operating profit for the quarter ended June 2023 decreased to 29.85 millions as compared to 66.04 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 212.37 218.78 -2.93 212.37 218.78 -2.93 805.93 1643.49 -50.96
Other Income 4.28 6.84 -37.43 4.28 6.84 -37.43 34.52 27.20 26.91
PBIDT 29.85 66.04 -54.80 29.85 66.04 -54.80 190.52 1002.19 -80.99
Interest 13.33 28.01 -52.41 13.33 28.01 -52.41 115.70 199.21 -41.92
PBDT 16.52 38.02 -56.55 16.52 38.02 -56.55 3.08 756.30 -99.59
Depreciation 33.35 34.14 -2.31 33.35 34.14 -2.31 135.16 153.89 -12.17
PBT -16.83 3.88 -533.76 -16.83 3.88 -533.76 -132.08 602.41 -121.93
TAX 0.37 0.61 -39.34 0.37 0.61 -39.34 0.78 203.38 -99.62
Deferred Tax -1.98 0.61 -424.59 -1.98 0.61 -424.59 -1.29 203.38 -100.63
PAT -17.20 3.27 -625.99 -17.20 3.27 -625.99 -132.86 399.03 -133.30
Equity 330.90 286.90 15.34 330.90 286.90 15.34 306.90 286.90 6.97
PBIDTM(%) 14.06 30.19 -53.44 14.06 30.19 -53.44 23.64 60.98 -61.23

Lyka Labs Share Price

78.32 -2.72 (-3.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×